Clinical Trial Update: Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating combined immunotherapy and targeted therapy for advanced liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: Guangxi Medical University | Conditions: Advanced Liver Cancer | Phase 3 | Status: UNKNOWN